Bio Essence Corporation (BIOE)
OTCMKTS · Delayed Price · Currency is USD
0.3000
+0.0260 (9.49%)
May 22, 2026, 4:00 PM EST

Bio Essence Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1.310.9-1.31-0.97-0.81-0.65
Depreciation & Amortization
00000.010.04
Loss (Gain) From Sale of Assets
--00.01--0
Asset Writedown & Restructuring Costs
--1.05---
Provision & Write-off of Bad Debts
-----0.01
Other Operating Activities
0.030.040.450.310.5-0.01
Change in Accounts Receivable
0-0.02-0.01-00.02
Change in Inventory
----0.030.06
Change in Accounts Payable
-0.020.030.01-0.01-0.020.01
Change in Income Taxes
0-0---0-0.01
Change in Other Net Operating Assets
-0.140.620.82-0.25-0.22-0.76
Operating Cash Flow
1.181.570.62-1.03-0.7-1.29
Operating Cash Flow Growth
53.86%151.62%----
Capital Expenditures
----0-0-0.12
Sale of Property, Plant & Equipment
-----0
Divestitures
---0---
Other Investing Activities
----0.09-0.06-
Investing Cash Flow
---0-0.09-0.06-0.12
Short-Term Debt Issued
-0.77-1.180.781.29
Long-Term Debt Issued
----0.060.17
Total Debt Issued
0.850.77-1.180.841.45
Short-Term Debt Repaid
--2.34-0.61---0.04
Long-Term Debt Repaid
--0-0-0-0-0
Total Debt Repaid
-2.44-2.34-0.61-0-0-0.05
Net Debt Issued (Repaid)
-1.59-1.57-0.611.180.841.41
Issuance of Common Stock
0.44-----
Other Financing Activities
---0.01-0.07-0.07-
Financing Cash Flow
-1.15-1.57-0.621.110.771.41
Net Cash Flow
0.04-00-0.010.01-0.01
Free Cash Flow
1.181.570.62-1.03-0.71-1.41
Free Cash Flow Growth
53.86%151.62%----
Free Cash Flow Margin
49.83%82.73%192.59%--113.74%-159.19%
Free Cash Flow Per Share
0.030.040.02-0.03-0.02-0.04
Cash Interest Paid
000.010.020.010.04
Cash Income Tax Paid
000000
Levered Free Cash Flow
0.290.810.12-0.33-0.25-0.85
Unlevered Free Cash Flow
0.290.810.13-0.33-0.24-0.83
Change in Working Capital
-0.160.630.82-0.26-0.2-0.68
Source: S&P Global Market Intelligence. Standard template. Financial Sources.